Bone is, together with kidney, the major target organ of PTH. It is known that PTH increases bone turnover, but it is obscure why in vivo it has an anabolic effect when it is administered intermittently, while its catabolic action prevails when it is given in a continuous fashion. PTH augments osteoclastic activity, but it is controversial whether its effects on osteoclasts are only mediated through osteoblasts, or whether they are also direct. Osteoblasts are the major target of PTH action. Which cells, however, in the osteoblast lineage- a spectrum from osteoprogenitors to pre-osteoblasts and mature osteoblasts - mediate the various actions of PTH in vivo is an open question. It is also unknown how PTHrP influenced osteoblast function independently of its role on chondrocyte differentiation. Finally, the cloned PTH/PTHrP receptor is able to activate at least two different signaling pathways, adenylate cyclase and phospholipase C. However, their relative importance in mediating the PTH effect on osteoblasts needs to be clarified. Recently the identification of two different mutations in the PTH/PTHrP receptor in patients with Jansen's metaphyseal chondrodysplasia (JMC), that lead to ligand-independent constitutive cAMP accumulation, gave us a powerful tool to explore experimentally at least some of the above mentioned questions. We propose to develop transgenic mice in which mutant PTH/PTHrP receptors will be expressed under the control of two different promoters. alpha1(I) collagen and osteocalcin promoters, to allow their targeted expression in less mature and/or more mature osteoblasts respectively (Specific Aim I). The analysis of these animals will help to determine and distinguish the roles of these cells in mediating the response to PTH and PTHrP (Specific Aim II). We also propose to mate these transgenic mice with the ones that selectively lack the PTH gene, to identify PTH effects on osteoblast function and maturation that are dependent on the PTH/PTHrP receptor activation of the cAMP pathway (Specific Aim III). Lastly, we will mate the above described transgenic mice with the animals that are resistant to collagenase-3 cleavage to confirm the importance of collagenase-3 induction for the bone remodeling process induced by PTH, both during development and in adult life (Specific Aim IV).

Project Start
1999-09-01
Project End
2000-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Yu, Elaine W; Neer, Robert M; Lee, Hang et al. (2011) Time-dependent changes in skeletal response to teriparatide: escalating vs. constant dose teriparatide (PTH 1-34) in osteoporotic women. Bone 48:713-9
Finkelstein, Joel S; Wyland, Jason J; Lee, Hang et al. (2010) Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 95:1838-45
Finkelstein, Joel S; Wyland, Jason J; Leder, Benjamin Z et al. (2009) Effects of teriparatide retreatment in osteoporotic men and women. J Clin Endocrinol Metab 94:2495-501
Leder, Benjamin Z; Neer, Robert M; Wyland, Jason J et al. (2009) Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis. J Clin Endocrinol Metab 94:2915-21
Finkelstein, Joel S; Leder, Benjamin Z; Burnett, Sherri-Ann M et al. (2006) Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men. J Clin Endocrinol Metab 91:2882-7
Kobayashi, Tatsuya; Kronenberg, Henry M; Foley, John (2005) Reduced expression of the PTH/PTHrP receptor during development of the mammary gland influences the function of the nipple during lactation. Dev Dyn 233:794-803
Miao, Dengshun; He, Bin; Jiang, Yebin et al. (2005) Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115:2402-11
Inada, Masaki; Wang, Yingmin; Byrne, Michael H et al. (2004) Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci U S A 101:17192-7
Kuznetsov, Sergei A; Riminucci, Mara; Ziran, Navid et al. (2004) The interplay of osteogenesis and hematopoiesis: expression of a constitutively active PTH/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow. J Cell Biol 167:1113-22
Chiusaroli, R; Maier, A; Knight, M C et al. (2003) Collagenase cleavage of type I collagen is essential for both basal and parathyroid hormone (PTH)/PTH-related peptide receptor-induced osteoclast activation and has differential effects on discrete bone compartments. Endocrinology 144:4106-16

Showing the most recent 10 out of 17 publications